Full Name
Catherine Sohn Pharm.D.
Job Title
Board Member
Company
Altimunne (ALT); Maze Therapeutics; BioEclipse Therapeutics; Life Sciences Cares Philadelphia
Speaker Bio
Dr. Catherine Sohn is an independent Director on the Board of Altimmune, Maze Therapeutics, and BioEclipse Therapeutics. Dr. Sohn is Chair of the Compensation Committee at Altimmune and is Chair of Nom/Gov Committee at Maze. Dr. Sohn particularly enjoys advising CEO and boards of private biotech companies.
Dr. Sohn has deep industry knowledge with thirty years of U.S. and global experience in the biopharmaceutical and consumer healthcare industries, and a reputation as a strategic thinker with the ability to foster a strong interface between research and development and marketing. Her areas of expertise include US and global business development, product strategy, and commercialization.
SOHN was named Distinguished Alumnus of the Year by the University of California, San Francisco in 2000, was recognized as Woman of the Year by the Healthcare Businesswomen's Association (HBA) in 2003, and received the Licensing Executive Society's Frank Barnes Mentoring Award (2009) and the HBA Euro-Excellence Award (2012). In 2016, Dr. Sohn was recognized as one of the PharmaVoice 100 most inspiring people in the life science industry.
Dr. Sohn received a Doctor of Pharmacy degree from the University of California, San Francisco; a Corporate Director Certificate from Harvard Business School; a Certificate of Professional Development from the Wharton School; a Certificate from Berkeley Law for ESG: Navigating the Board's Role; and is a Certified Licensing Professional Emeritus.
Dr. Sohn has deep industry knowledge with thirty years of U.S. and global experience in the biopharmaceutical and consumer healthcare industries, and a reputation as a strategic thinker with the ability to foster a strong interface between research and development and marketing. Her areas of expertise include US and global business development, product strategy, and commercialization.
SOHN was named Distinguished Alumnus of the Year by the University of California, San Francisco in 2000, was recognized as Woman of the Year by the Healthcare Businesswomen's Association (HBA) in 2003, and received the Licensing Executive Society's Frank Barnes Mentoring Award (2009) and the HBA Euro-Excellence Award (2012). In 2016, Dr. Sohn was recognized as one of the PharmaVoice 100 most inspiring people in the life science industry.
Dr. Sohn received a Doctor of Pharmacy degree from the University of California, San Francisco; a Corporate Director Certificate from Harvard Business School; a Certificate of Professional Development from the Wharton School; a Certificate from Berkeley Law for ESG: Navigating the Board's Role; and is a Certified Licensing Professional Emeritus.
Speaking At
